Better yet, wait 6-8 weeks if you are experiencing fatigue or significant GI symptoms at your current dose
Why Joint Pain May Occur During GLP-1 Treatment Rapid weight loss altering joint biomechanics is the most likely indirect cause of joint pain during GLP-1 treatment, rather than a direct drug effect
This condition is linked to a variety of severe health problems, including Type 2 Diabetes, stroke, myocardial infarction , and other cardiovascular diseases
One older study on Byetta (exenatide) showed minimal transfer, but there are no studies on semaglutide, tirzepatide, or liraglutide in breast milk, and no data on infant outcomes when exposed via breast milk
Where is visceral fat located